BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 28379101)

  • 1. Characteristics and clinical assessment of antibiotic delivery by chitosan sponge in the high-risk diabetic foot: a case series.
    Patel N; Hatch D; Wells CM; Ahn D; Harris M; Jennings JA; Haggard W; Armstrong DG
    J Wound Care; 2017 Apr; 26(sup4):S32-S38. PubMed ID: 28379101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local control of polymicrobial infections via a dual antibiotic delivery system.
    Tennent DJ; Shiels SM; Jennings JA; Haggard WO; Wenke JC
    J Orthop Surg Res; 2018 Mar; 13(1):53. PubMed ID: 29544509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibacterial activity and drug release of chitosan sponge containing doxycycline hyclate.
    Phaechamud T; Charoenteeraboon J
    AAPS PharmSciTech; 2008; 9(3):829-35. PubMed ID: 18626774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local Antibiotic Delivery Systems: Current and Future Applications for Diabetic Foot Infections.
    Markakis K; Faris AR; Sharaf H; Faris B; Rees S; Bowling FL
    Int J Low Extrem Wounds; 2018 Mar; 17(1):14-21. PubMed ID: 29458291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blended Chitosan Paste for Infection Prevention: Preliminary and Preclinical Evaluations.
    Berretta JM; Jennings JA; Courtney HS; Beenken KE; Smeltzer MS; Haggard WO
    Clin Orthop Relat Res; 2017 Jul; 475(7):1857-1870. PubMed ID: 28097503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Innovative Technique in Local Antibiotic Delivery Method in Open Infected Wounds of the Musculoskeletal System.
    Shekhar C
    Int J Low Extrem Wounds; 2019 Jun; 18(2):153-160. PubMed ID: 31066316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chitosan-hyaluronic acid/nano silver composite sponges for drug resistant bacteria infected diabetic wounds.
    Anisha BS; Biswas R; Chennazhi KP; Jayakumar R
    Int J Biol Macromol; 2013 Nov; 62():310-20. PubMed ID: 24060281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic review of local antibiotic devices used to improve wound healing following the surgical management of foot infections in diabetics.
    Marson BA; Deshmukh SR; Grindlay DJC; Ollivere BJ; Scammell BE
    Bone Joint J; 2018 Nov; 100-B(11):1409-1415. PubMed ID: 30418057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Effective Negative Pressure Wound Therapy-Compatible Local Antibiotic Delivery Device.
    Rand BCC; Wenke JC
    J Orthop Trauma; 2017 Dec; 31(12):631-635. PubMed ID: 28742785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chitosan sponges to locally deliver amikacin and vancomycin: a pilot in vitro evaluation.
    Noel SP; Courtney HS; Bumgardner JD; Haggard WO
    Clin Orthop Relat Res; 2010 Aug; 468(8):2074-80. PubMed ID: 20352389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a chitosan-polyethylene glycol paste as a local antibiotic delivery device.
    Rhodes CS; Alexander CM; Berretta JM; Courtney HS; Beenken KE; Smeltzer MS; Bumgardner JD; Haggard WO; Jennings JA
    World J Orthop; 2017 Feb; 8(2):130-141. PubMed ID: 28251063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chitosan Sponges Are Associated With Higher Rates of Wound Complications Compared to Calcium Sulfate Beads.
    McKee K; Easton J; Mullis B; Hadad I
    Cureus; 2023 May; 15(5):e38490. PubMed ID: 37273303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Designed sponges based on chitosan and cyclodextrin polymer for a local release of ciprofloxacin in diabetic foot infections.
    Gauzit Amiel A; Palomino-Durand C; Maton M; Lopez M; Cazaux F; Chai F; Neut C; Foligné B; Martel B; Blanchemain N
    Int J Pharm; 2020 Sep; 587():119677. PubMed ID: 32717280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic therapy for diabetic foot infections in a tertiary care hospital in Jakarta, Indonesia.
    Radji M; Putri CS; Fauziyah S
    Diabetes Metab Syndr; 2014; 8(4):221-4. PubMed ID: 25311820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In diabetic foot infections antibiotics are to treat infection, not to heal wounds.
    Abbas M; Uçkay I; Lipsky BA
    Expert Opin Pharmacother; 2015 Apr; 16(6):821-32. PubMed ID: 25736920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tetracycline release from tripolyphosphate-chitosan cross-linked sponge: a preliminary in vitro study.
    Shen EC; Wang C; Fu E; Chiang CY; Chen TT; Nieh S
    J Periodontal Res; 2008 Dec; 43(6):642-8. PubMed ID: 18624950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic reviews of wound care management: (3) antimicrobial agents for chronic wounds; (4) diabetic foot ulceration.
    O'Meara S; Cullum N; Majid M; Sheldon T
    Health Technol Assess; 2000; 4(21):1-237. PubMed ID: 11074391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility patterns of Staphylococcus aureus biofilms in diabetic foot infections.
    Mottola C; Matias CS; Mendes JJ; Melo-Cristino J; Tavares L; Cavaco-Silva P; Oliveira M
    BMC Microbiol; 2016 Jun; 16(1):119. PubMed ID: 27339028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydrogel Dressing with a Nano-Formula against Methicillin-Resistant Staphylococcus aureus and Pseudomonas aeruginosa Diabetic Foot Bacteria.
    El-Naggar MY; Gohar YM; Sorour MA; Waheeb MG
    J Microbiol Biotechnol; 2016 Feb; 26(2):408-20. PubMed ID: 26597531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a Novel Collagen Wound Model To Simulate the Activity and Distribution of Antimicrobials in Soft Tissue during Diabetic Foot Infection.
    Price BL; Lovering AM; Bowling FL; Dobson CB
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6880-6889. PubMed ID: 27620475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.